CHIEF COMPLAINT

Abnormal labs.

HISTORY OF PRESENT ILLNESS

John Brooks is a 55-year-old male with a past medical history significant for anxiety and epilepsy, who presents with an abnormal lab finding.

The patient was notified by the emergency room physician that he had elevated blood sugar levels. He was started on metformin 500 mg twice daily during that time. He notes that he has going from place to place for different events and they've recently had a lot of visitors; therefore, he was not monitoring his sugar intake over the last few weeks.

In terms of his anxiety, he states he has had his moments, but now that it is almost the weekend, his symptoms have improved.

Regarding his epilepsy, he has not had any seizures in a few months. He continues to take Keppra.

The patient denies chest pain, shortness of breath, vomiting, dizziness, fevers, and chills.

REVIEW OF SYSTEMS

• Constitutional: Denies fevers, chills.
• Cardiovascular: Denies chest pain or dyspnea.
• Respiratory: Denies shortness of breath.
• Neurological: Endorses epilepsy.
• Psychiatric: Endorses anxiety.

PHYSICAL EXAMINATION

• Respiratory: Lungs are clear to auscultation bilaterally. No wheezes, rales, or rhonchi.
• Cardiovascular: Regular rate and rhythm.
• Musculoskeletal: Trace pitting edema to the bilateral lower extremities.

RESULTS

Hemoglobin A1c is elevated at 8.

Non-fasting glucose is elevated.

ASSESSMENT AND PLAN

John Brooks is a 55-year-old male with a past medical history significant for anxiety and epilepsy. He presents today with an abnormal lab finding.

Newly diagnosed diabetes.
• Medical Reasoning: His past hemoglobin A1c levels have been borderline high, but his most recent level was 8. His blood glucose level is also elevated in clinic today.
• Additional Testing: Repeat hemoglobin A1c.
• Medical Treatment: Continue metformin 500 mg twice daily.

Epilepsy.
• Medical Reasoning: He saw his neurologist about 3 months ago and has been asymptomatic for the past few months.
• Medical Treatment: Continue Keppra at current dosage.

Patient Agreements: The patient understands and agrees with the recommended medical treatment plan.
